$Sun Pharma and Israel-based Moebius Medical have announced that the US Food and Drug Administration (FDA) has granted fast-frack designation (FTD) to MM-II (large liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain.$

FDA go-ahead to Sun Pharma to develop osteoarthritis knee pain drug

HTP Desk - September 7, 2024 0

Phase 3 clinical trial of India’s 1st indigenous dengue vaccine

HTP Desk - August 21, 2024 0

Pierre Fabre Laboratories receives CHMP positive opinion for Braftovi in combination...

HTP Desk - July 30, 2024 0

DocMode launches clinical research services

HTP Desk - July 16, 2024 0

Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.

This function has been disabled for HealthTekPak.

error: Content is protected !!